The Role of Congenital Mucosal Immune System in the Airways of Patients With Chronic Obstructive Pulmonary Disease
NCT04061122 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2019-08-19
Summary
The purpose of the study is to explore the role of congenital mucosal immune system in the airways of patients with COPD including the impact of ILCs (Innate lymphoid cells) on metabolism of epithelial cells.During the research the following methods will be applied: measurement of Volatile Organic Compounds (VOCS), airway epithelial cytology and culture.
Conditions
- COPD Exacerbation
- Smoking, Tobacco
Interventions
- DIAGNOSTIC_TEST
-
airway epithelial smear test
all patients will be subjected to all scheduled procedures: airways epithelial smear test, measurement of VOCs in exhaled air and airways slide sample culture
Sponsors & Collaborators
-
Medical University of Lodz
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-04
- Primary Completion
- 2020-01-30
- Completion
- 2020-06-30
Countries
- Poland
Study Locations
More Related Trials
-
A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations
NCT01337661 ·Status: COMPLETED
-
Bronchial Infection in Patients With COPD and Frequent Exacerbations.
NCT03259022 ·Status: UNKNOWN
-
Respiratory Microbiome in COPD and Associated Inmune Response.
NCT03321708 ·Status: UNKNOWN
-
Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases
NCT02807025 ·Status: UNKNOWN
-
Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT00281242 ·Status: COMPLETED
-
Leukocyte Function in Asthma and COPD
NCT00147069 ·Status: COMPLETED
-
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
NCT00281216 ·Status: COMPLETED
-
Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung
NCT05846620 ·Status: RECRUITING
-
Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease
NCT00147095 ·Status: COMPLETED
-
Innate Immune Response in COPD
NCT02637219 ·Status: COMPLETED
-
Evaluation of Immunological, Microbiological and Metabolomic Profiles in COPD
NCT06826560 ·Status: COMPLETED
-
Airway Inflammation and Remodeling in Asthma and COPD.
NCT02069054 ·Status: COMPLETED
-
Role of Fibrocytes in Chronic Obstructive Pulmonary Disease
NCT01196832 ·Status: COMPLETED
-
Leukocyte Function in Chronic Obstructive Pulmonary Disease (COPD)
NCT00147082 ·Status: COMPLETED
-
The Expression of TLR2 and TLR4 in the Lung of Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01226199 ·Status: UNKNOWN
-
Innate Immunity in COPD
NCT05743582 ·Status: RECRUITING
-
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
NCT00470327 ·Status: RECRUITING
-
Biomarkers of Chronic Obstructive Pulmonary Disease
NCT04963023 ·Status: COMPLETED
-
Mechanisms of Lung Defense and Their Relationship With Airway Infection in Chronic Obstructive Pulmonary Disease (COPD)
NCT01976130 ·Status: UNKNOWN ·Phase: NA
-
Respiratory Microbiota, Infection Characteristics and Imaging Manifestations in Patients With Chronic Airway Inflammation
NCT06938022 ·Status: NOT_YET_RECRUITING
-
Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)
NCT00655694 ·Status: WITHDRAWN
-
Blood Eosinophil Measurements in Patients With Chronic Obstructive Pulmonary Disease
NCT03853642 ·Status: COMPLETED
-
Ciliation and Mucus Rheology Parameters Determined Via Air-liquid-interface Cell Cultures in Non-smoking, Smoking, COPD and Asthmatic Patients
NCT03187860 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Eosinophil Phenotype in COPD Patients
NCT04494308 ·Status: UNKNOWN
-
The Role of Airway Microbiota on Clinical Phenotypes and Disease Severity in Bronchiectasis
NCT05068518 ·Status: UNKNOWN